PhD students in Molecular Medicine

Description: The NCMM research area is focused on disease mechanisms and looking towards personalized medicine with the goal of building a bridge from disease mechanisms to clinical practice. The selected candidates will be offered an initial contract for a three-year period, starting in 2011 and the candidates will be required to register with a facultary PhD programme at University of Oslo.

Qualification and experience: Positions are open for graduate students with a relevant background in biology, biochemistry, biotechnology, medicine or other related fields. To be eligible, the student must have obtained an academic degree (MSc, MD or equivalent) before starting. Good communications skills and ability to work within an international team are essential.

Application and selection process: The application is submitted online and should include:

1) A complete application, specifying which the NCMM research group the candidate applies to.

2) A one-page statement of motivation and research interests

3) CV

4) Copies of Graduation Certificates

5) Names and contact details of 2-3 references (name, relation to candidate, e-mail and telephone number)

The submission deadline is February 15, 2011. Applications submitted after the deadline will not be accepted.

The top candidates will be invited for an interview with the Search Committee.

The positions will be placed as SKO 1017, with salary range depending on qualifications: salary step 48-52 (NOK 383.900 – 411.000). UiO requires that all employees sign an agreement regarding acquisition intellectual property rights to work results that are produced by the employee.

Research Areas of NCMM and Principal Investigators

The overall objective of NCMM is to facilitate translation of discoveries in basic medical research into clinical practice. NCMM will focus particularly on disease mechanisms where Norway has clear strengths and will investigate mechanisms of non-communicable diseases such as cancer, cardiovascular and CNS-related disease and immune disorders. The Nordic EMBL partnership aims to exploit emerging technologies as part of a process towards molecular and personalized medicine and will capitalize on synergies within the Nordic region. NCMM will develop and adapt technologies for personalized medical applications and will be expected to unravel new diagnostic methods and drug targets.

NCMM has three founding partners (O.P.Ottersen, K.Taskén, S.Krauss) and four new group leaders, Dr. Ian G. Mills, Dr. Erlend A. Nagelhus, Dr. Preben Morth and Professor Kjetil Taskén, who is also the Director of NCMM. Two additional group leaders will be hired this year.

Requests for further information and inquiries regarding the open posts and projects can be directed to Group Leaders:

Kjetil Taskéns’ Group:
Cell Signaling and Immunomodulation,
PhD Project: Therapeutic strategies to interfere with inhibition of anti-tumor immunity by regulatory T cells
Funding source: Research Council of Norway

Ian Mills’ Group:
Prostate Cancer Laboratory,
PhD-project: The identification and characterisation of prostate cancer biomarkers from transcriptional networks.
Funding source: Norwegian Cancer Society

Preben Morths’ Group:
Membrane Transport, 
PhD-project: Structural studies of membrane transporters in PH regulation.
Funding source: NCMM

For further information please visit our website: www.ncmm.uio.no

Requests for application information should be directed to CAO Elin Kaurstad,e.k.kaurstad@ncmm.uio.no

• Region:
• Oslo

• Job type:
• Contract

• Working hours:
• Full-time

• Working days:
• Day

• Application deadline:
• 15.02.2011

• Location:
• NCMM, University of Oslo

• Reference number:
• 2011/234

• Home page:
• http://www.ncmm.uio.no/

• Contacts:
• CAO Elin Kaurstad 
  Telephone: +47 22840608 
  Mobile: +47 91611585

Send application